Testing effectiveness (Phase 2)Study completedNCT02144025
What this trial is testing
Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
Who this might be right for
Graft-Versus-Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 21